The company has mandated Avendus Capital to run a formal process to find a buyer.

K. Taraka Rama Rao, Telangana's industries minister attributed this to the lack of people’s confidence in government healthcare institution...

In an exclusive interview to ET Now, Glenn Saldanha, CMD, Glenmark, said next few quarters will be strong due to gZetia.

Brokerage firms that were bullish on Indian drug makers are also feeling the jitters of the DOJ investigation and the threat of free market...

"With slowdown in India, we are not sure how things will pan out going forward, but the 30% growth is not sustainable going forward," says ...

Glenmark surged over 4% to hit its 52-week high of Rs 519.70 after the company said its subsidiary has signed an agreement with Forest Labs.

'We will see a lot of change in pharma due to problems in big firms such as drying up of product pipelines & poor R&D.'

Glen Saldanha, Managing Director & CEO, Glenmark Pharmaceuticals speaks to ET Now. Excepts from the interview.

Glenmark Generics, the generics arm of Glenmark Pharmaceuticals, on Wednesday filed the draft prospectus with Sebi to raise Rs 550-600 cror...

The drug industry is pinning its hopes on Obama-led Democrat government to increase its sales in the US as the new administration plans to ...

Glenmark Pharmaceuticals on Friday said it would look at out-licensing two of its molecules this year that are in clinical trials.

Glenmark pharmaceuticals on Monday announced acquisition of 90% stake in Czech firm Medicamenta to get a commercial foothold in the strateg...

Glenmark Pharmaceuticals Inc (GPI) has signed a $ 27 million royalty deal with international healthcare investment fund Paul Capital Partne...